Company news

Recce Pharmaceuticals Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

USA Patent Granted for Recces Antibiotics

March 13, 2019

Recce Successfully Raises $1.8 million via Placement

February 7, 2019

Change of Registry Address: Automic P/L - Sydney Office

September 28, 2018

Key Australian Patent for Recces Broad-Spectrum Antibiotics

July 31, 2018

Update on Progress of Broad Spectrum Antibiotic RECCE 327

July 18, 2018

Update on meeting with US FDA

June 5, 2018

Additional AU$861,590 R&D Tax Incentive Rebate Received

April 22, 2018

Recce Half Yearly Report and Appendix 4D

February 28, 2018

Data Submission & Further Communication Request with US FDA

February 14, 2018

AusIndustry Awards Recce Financial Support

January 14, 2018

US FDA Grants Qualified Infectious Disease Product Designati

November 15, 2017

Appendix 4C - quarterly

October 31, 2017

Recce Launches Share Purchase Plan

September 27, 2017

Response to ASX Price Query

September 18, 2017

Recce Confirms Pre-IND Data Submission to US FDA

September 6, 2017

Appendix 4E and Financial Report

August 31, 2017

Recce Confirms Delivery by Intravenous Drip

July 30, 2017

Recce achieves milestone with volume production

July 19, 2017

Recce constructs automated manufacturing facility to support

June 22, 2017

Recce secures up to A$6.05 million investment agreement with

June 16, 2017

Recce moves closer to clinical study application

May 19, 2017

Operational Update

April 9, 2017

Data from large animal study shows RECCE 327 well tolerated

March 26, 2017

Appendix 4D and Interim Financial Statements

February 28, 2017

Microscopy Images of its Synthetic Antibiotic in Action Dest

February 23, 2017

Recce to suspend anti-cancer program

February 22, 2017

Operational Update and Quarterly Cash Flow

January 30, 2017

Lead compound reduces illness in mice infected by E.coli

January 17, 2017

Encouraging anti-viral activity for lead compound RECCE 327

December 20, 2016

Pre-clinical toxicology and efficacy testing

November 2, 2016

Dose Ranging in Mice - Repeated Success

August 15, 2016

Successful Test Results for Genetic Toxicity

July 20, 2016

Anti-viral Activity

July 13, 2016

Update on Testing Schedules

June 20, 2016

Encouraging Results from Safety Test

May 25, 2016

Recce - The Way Forward

May 2, 2016

Progress Update

April 10, 2016

International Trade Mark Registrations

April 5, 2016

Anti-cancer Activities

March 13, 2016

Appendix 4D and Half Year Financial Statements

February 26, 2016

Efficacy without Toxicity

February 11, 2016

RECCE Antibiotic kills TB and Gonorrhoea

February 10, 2016

Patent Granted in China

February 10, 2016

Admission to Official List

February 10, 2016

Additional Patent Developments

February 10, 2016

← Newer news releases

Decks

The 5 newest of 26 decks. Every deck is listed under its year.